Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05637814 · ClinicalTrials.gov registry record · NA
Dynamic Critical Congenital Heart Screening With Addition of Perfusion Measurements
A NA study of Congenital Heart Disease, sponsored by University of California, Davis.
- Completed
- Registry status
- NA
- Development phase
- 51
- Enrollment target
- 3
- Study locations
NCT05637814: Completed NA study of Congenital Heart Disease, sponsored by University of California, Davis.
NCT05637814 is a NA study of Congenital Heart Disease that has completed, run by University of California, Davis. The registered enrollment target is 51 participants, below the 473-participant average among 63 other Congenital Heart Disease trials with a reported enrollment target (89% lower). The trial reports 3 study locations across 3 states. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT05637814, a NA study of Congenital Heart Disease, has completed, sponsored by University of California, Davis.
- COMPLETED
- Registry status
- NA
- Development phase
- 51 participants
- Enrollment target
- 3
- Study locations
Study Summary
The purpose of this study is to implement and externally validate an inpatient ML algorithm that combines pulse oximetry features for critical congenital heart disease (CCHD) screening.
Primary Outcome
Receiver operating characteristics reflect a combination of sensitivity and specificity of a test. The investigators will identify the true positive and true negative rates for CCHD by confirming health status to a minimum of 2 months of age. The investigators will also utilize birth defect and death registries for missing infants.
Conditions Studied
Interventions
- DIAGNOSTIC_TEST SpO2/PIx Measurement and ML Algorithm
Study Locations (3)
California
- UC Davis Medical Center - Davis
New York
- Cohen Children's Medical Center - Queens
Utah
- University of Utah Health Care - Salt Lake City
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 51 participants |
| Start Date | 2023-08-17 |
| Est. Completion | 2024-08-02 |
| Phase | NA |
What the finished NCT05637814 record still lists
NCT05637814 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 51 participants, a relatively small participant target, below the 473-participant average among 63 other Congenital Heart Disease trials with a reported enrollment target (89% lower).
The record links to 1 condition, with Congenital Heart Disease appearing as the primary indexed condition, and to 1 intervention - of which SpO2/PIx Measurement and ML Algorithm is the first listed.
NCT05637814 reports a single indexed study location in California, New York, Utah.
Frequently Asked Questions
What is clinical trial NCT05637814 about?
NCT05637814 is a clinical study titled "Dynamic Critical Congenital Heart Screening With Addition of Perfusion Measurements". The purpose of this study is to implement and externally validate an inpatient ML algorithm that combines pulse oximetry features for critical congenital heart disease (CCHD) screening.
What is the current status of trial NCT05637814?
This trial is currently completed. It is a NA study. The enrollment target is 51 participants. The study started on 2023-08-17. Estimated completion is 2024-08-02.
What conditions does trial NCT05637814 study?
This clinical trial studies the following conditions: Congenital Heart Disease.
What interventions are being tested in trial NCT05637814?
The interventions under investigation include: SpO2/PIx Measurement and ML Algorithm (DIAGNOSTIC_TEST).
Who is sponsoring clinical trial NCT05637814?
This trial is sponsored by University of California, Davis, which has 657 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT05637814 being conducted?
This trial has 3 study locations across California, New York, Utah. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Congenital Heart Disease
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT05637814's enrollment target sits among peer trials
51 39th of 63 higher than 24 of 63 other Congenital Heart Disease trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Congenital Heart Disease trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Fontan Fitness Trial
RECRUITING · NA
-
Blood Conservation in Patients (3.5-12kg) Undergoing Congenital Cardiac Surgery
RECRUITING · NA
-
The Sequencing for Detection in Congenital Heart Disease (SD-CHD) Study
RECRUITING · NA
-
Starlight Cardiovascular Lifeline Ductus Arteriosus Stent IDE Study
RECRUITING · NA
-
A Study of Hemodynamic Cardiopulmonary Exercise for CHD
RECRUITING · NA
-
Ventripoint Single Ventricle Study
RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02701153 · 51 participants · NA
Phase II Study of 5-Day Hypofractionated Preoperative Radiation Therapy for Soft Tissue Sarcomas: Expansion Cohort
- NCT03663790 · 51 participants · NA
Effects of Gait Retraining on Lower Extremity Biomechanics
- NCT03874052 · 51 participants · Phase 1
Ruxolitinib in Combination With Venetoclax With and Without Azacitidine in Treating Patients With Relapsed or Refractory Acute Myeloid Leukemia
- NCT04704661 · 51 participants · Phase 1
Testing the Combination of Two Anti-cancer Drugs, DS-8201a and AZD6738, for The Treatment of Advanced Solid Tumors Expressing the HER2 Protein or Gene, The DASH Trial
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI